- Price
- $31.48
- Day
- -0.16%
- Mkt Cap
- $2.47B
- 52W Range
- $16.10 – $33.07
- Volume
- 703.4K
- Beta
- 1.02
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Progyny (PGNY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read full article
NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, will report its financial results for the quarterly period ended June 30, 2026 after the close of the market on Thursday, August 6, 2026.
Read full article
Melissa B. Cummings disposed of 3,437 shares for a total value of ~$109,000 on July 14, 2026. The transaction reduced the insider's direct equity holdings by 5%.
Read full article
JBHT, PGNY, BSET, VSXY and PARR stand out for relative price strength, positive estimate revisions and solid fundamentals amid market uncertainty.
Read full article
Progyny (PGNY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Read full article